Eledon Pharmaceuticals (ELDN) Goodwill (2017 - 2022)

Eledon Pharmaceuticals has reported Goodwill for 6 years, with the latest figure at $48.6 million in Q3 2022.

• For the quarter ending Q3 2022, Goodwill changed 0.0% year-over-year to $48.6 million; the trailing twelve-month figure through Sep 2022 stood at $48.6 million (changed 0.0% YoY), and the FY2021 full-year result was $48.6 million, changed 0.0% from the prior year.
• Goodwill for Q3 2022 stood at $48.6 million, roughly flat from $48.6 million in the prior quarter.
• The five-year high for Goodwill was $48.6 million in Q4 2020, with the low at $1.9 million in Q1 2018.
• Historically, Goodwill has averaged $27.9 million across 5 years, with a median of $46.6 million in 2020.
• Annual changes were most pronounced in 2018 — Goodwill changed 0.0% — and 2020, when it jumped 2281.68%.
• Eledon Pharmaceuticals' Goodwill stood at $1.9 million in 2018, then changed by 0.0% to $1.9 million in 2019, then surged by 2505.68% to $48.6 million in 2020, then changed by 0.0% to $48.6 million in 2021, then changed by 0.0% to $48.6 million in 2022.
• The last three Goodwill figures came in at $48.6 million (Q3 2022), $48.6 million (Q2 2022), and $48.6 million (Q1 2022), per Business Quant data.